Vinoshene Pillai,Silvia Landi,Francesca Uccheddu et al.
Vinoshene Pillai et al.
Purpose: The emergence of focal techniques such as stereotactic radiosurgery has led to a more selective use of whole brain radiotherapy (WBRT), yet it remains an important modality for treating diffuse or multiple intrac...
Reirradiation of locally recurrent prostate Cancer: a review of prospective evidence and delineation and planning strategies from the reirradiation Collaborative group (ReCOG) [0.03%]
局部复发前列腺癌的再放疗：来自再放疗协作组（ReCOG）的前瞻性证据和靶区及计划策略综述
Finbar Slevin,Brad Warkentin,Jeremy Hansen et al.
Finbar Slevin et al.
There is considerable uncertainty regarding the optimum approaches to target volume and organ at risk (OAR) delineation and tolerances to reirradiation for locally recurrent prostate cancer. To address these uncertainties, we undertook a li...
Can stereotactic body radiotherapy replace brachytherapy in gynecologic cancers? A systematic review of current evidence [0.03%]
立体定向体放射治疗能否替代妇科肿瘤的近距离放疗？目前证据的系统回顾
Paula Vicente Ruiz,Ana Illescas Vacas,Ángel Vilches Arenas
Paula Vicente Ruiz
Brachytherapy (BT) is a cornerstone of curative radiotherapy for gynecologic cancers due to its ability to deliver high intratumoral doses with steep dose gradients. Limited availability and declining utilization have increased interest in ...
Real-world implementation of a pre-consultation patient educational tool for intermediate risk prostate cancer [0.03%]
实用工具：帮助中危前列腺癌患者术前教育咨询的功能性应用实施
Mariana Borras-Osorio,Roman O Kowalchuk,Heather R Preston et al.
Mariana Borras-Osorio et al.
Background: Prostate Cancer (PCa) decision-making requires patients to understand their diagnosis and therapeutic options, balancing care nuances and risk-to-benefit profiles. The complexity of information and a wide rang...
Efficacy and safety of low-dose radiotherapy in MRI-confirmed refractory chronic plantar fasciitis after extracorporeal shock wave therapy [0.03%]
磁共振确诊的富血小板浆治疗失败的慢性足底筋膜炎患者低剂量放射治疗的有效性和安全性
Manuel Novo-Rigueiro,Fabio Pires-Pereira,Ignacio Lete-Achirica et al.
Manuel Novo-Rigueiro et al.
Background: Refractory chronic plantar fasciitis remains a therapeutic challenge when symptoms persist despite conservative management and advanced physical therapies. Although low-dose radiotherapy has been used as an an...
Real-world outcomes of stage III non-small cell lung cancer in the durvalumab era: insights from a socioeconomically deprived population [0.03%]
杜瓦鲁单抗时代三期非小细胞肺癌的真实世界结局——来自贫困地区人群的启示
Adam L Peters,Harrison Douglas Stubbs,Sean F Duncan et al.
Adam L Peters et al.
Background: The introduction of consolidation durvalumab after chemoradiotherapy (CRT) for unresectable stage 3 non-small cell lung cancer (NSCLC), as established by the PACIFIC trial, has transformed survival outcomes. H...
Early and late CTCAE and patient-reported outcomes following prostate radiotherapy in the REQUITE cohort [0.03%]
REQUITE队列中前列腺放疗后早期和晚期CTCAE及患者报告结果的评估
Philipp Heumann,Juan Camilo Rosas Romero,Miguel E Aguado Barrera et al.
Philipp Heumann et al.
Background: Prospectively collected long-term adverse event data with pre-radiotherapy assessment and regular follow-up reflecting 'real world settings' are still limited. Here, we present the available data on early and ...
Severe primary organ-related complications in patients with de novo metastatic cancer: implications for prophylactic local therapy [0.03%]
原发器官功能严重并发症与初诊转移癌患者序贯局部预防性治疗的意义
Hefei Liu,Dafna Merhav,Naia Tabakovic et al.
Hefei Liu et al.
Purpose: Patients with de novo metastatic cancer develop local organ-related complications leading to hospitalizations, procedures, and reduced quality of life. Prophylactic local therapy (e.g., radiotherapy) has been pro...
Simultaneous integrated boost vs sequential boost chemoradiotherapy in anal squamous cell carcinoma: Association with improved disease-free survival and the role of treatment delivery parameters [0.03%]
术中同时 boost 和序贯 boost 放化疗在肛管鳞癌中的应用：与无病生存改善相关及治疗参数的作用分析
Cécile Giannetta,Rafik Nebbache,Isabelle Etienney et al.
Cécile Giannetta et al.
Background and purpose.The optimal radiotherapy delivery strategy for anal canal cancer remains debated. We compared outcomes between simultaneous integrated boost (SIB) and sequential boost approaches in patients treated with chemoradiothe...
Magnetic resonance imaging findings after stereotactic body radiation therapy for hepatocellular carcinoma - a scoping literature review [0.03%]
立体定向体放射治疗后肝细胞癌的磁共振成像表现-系统综述文献回顾研究
Caglayan Lara,Gkika Eleni,Péporté Anne et al.
Caglayan Lara et al.
Stereotactic body radiotherapy (SBRT) is an established locoregional treatment option for hepatocellular carcinoma (HCC). However, post-treatment imaging remains challenging because tumor response and focal liver reaction (FLR), defined as ...